These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The promise of bacteriophage therapy for Burkholderia cepacia complex respiratory infections. Semler DD; Lynch KH; Dennis JJ Front Cell Infect Microbiol; 2011; 1():27. PubMed ID: 22919592 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of bacteriophage therapy in a model of Burkholderia cenocepacia pulmonary infection. Carmody LA; Gill JJ; Summer EJ; Sajjan US; Gonzalez CF; Young RF; LiPuma JJ J Infect Dis; 2010 Jan; 201(2):264-71. PubMed ID: 20001604 [TBL] [Abstract][Full Text] [Related]
4. Experimental bacteriophage therapy increases survival of Galleria mellonella larvae infected with clinically relevant strains of the Burkholderia cepacia complex. Seed KD; Dennis JJ Antimicrob Agents Chemother; 2009 May; 53(5):2205-8. PubMed ID: 19223640 [TBL] [Abstract][Full Text] [Related]
5. Synergistic Interactions among Lauman P; Dennis JJ Microbiol Spectr; 2023 Jun; 11(3):e0443022. PubMed ID: 37195168 [TBL] [Abstract][Full Text] [Related]
6. The temperate Burkholderia phage AP3 of the Peduovirinae shows efficient antimicrobial activity against B. cenocepacia of the IIIA lineage. Roszniowski B; Latka A; Maciejewska B; Vandenheuvel D; Olszak T; Briers Y; Holt GS; Valvano MA; Lavigne R; Smith DL; Drulis-Kawa Z Appl Microbiol Biotechnol; 2017 Feb; 101(3):1203-1216. PubMed ID: 27770178 [TBL] [Abstract][Full Text] [Related]
7. Cangene gold medal award lecture - Genomic analysis and modification of Burkholderia cepacia complex bacteriophages. Lynch KH; Dennis JJ Can J Microbiol; 2012 Mar; 58(3):221-35. PubMed ID: 22339239 [TBL] [Abstract][Full Text] [Related]
8. Burkholderia cepacia complex Phage-Antibiotic Synergy (PAS): antibiotics stimulate lytic phage activity. Kamal F; Dennis JJ Appl Environ Microbiol; 2015 Feb; 81(3):1132-8. PubMed ID: 25452284 [TBL] [Abstract][Full Text] [Related]
9. Toward modern inhalational bacteriophage therapy: nebulization of bacteriophages of Burkholderia cepacia complex. Golshahi L; Seed KD; Dennis JJ; Finlay WH J Aerosol Med Pulm Drug Deliv; 2008 Dec; 21(4):351-60. PubMed ID: 18800880 [TBL] [Abstract][Full Text] [Related]
10. Advances in Phage Therapy: Targeting the Lauman P; Dennis JJ Viruses; 2021 Jul; 13(7):. PubMed ID: 34372537 [TBL] [Abstract][Full Text] [Related]
11. In vitro lung delivery of bacteriophages KS4-M and ΦKZ using dry powder inhalers for treatment of Burkholderia cepacia complex and Pseudomonas aeruginosa infections in cystic fibrosis. Golshahi L; Lynch KH; Dennis JJ; Finlay WH J Appl Microbiol; 2011 Jan; 110(1):106-17. PubMed ID: 20875034 [TBL] [Abstract][Full Text] [Related]
12. Activity of Aerosolized Levofloxacin against Burkholderia cepacia in a Mouse Model of Chronic Lung Infection. Sabet M; Griffith DC Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712215 [No Abstract] [Full Text] [Related]
14. Hypermutation in Burkholderia cepacia complex is mediated by DNA mismatch repair inactivation and is highly prevalent in cystic fibrosis chronic respiratory infection. Martina P; Feliziani S; Juan C; Bettiol M; Gatti B; Yantorno O; Smania AM; Oliver A; Bosch A Int J Med Microbiol; 2014 Nov; 304(8):1182-91. PubMed ID: 25217078 [TBL] [Abstract][Full Text] [Related]
15. Can early Burkholderia cepacia complex infection in cystic fibrosis be eradicated with antibiotic therapy? Horsley A; Webb K; Bright-Thomas R; Govan J; Jones A Front Cell Infect Microbiol; 2011; 1():18. PubMed ID: 22919584 [TBL] [Abstract][Full Text] [Related]
16. Harnessing the Diversity of Nordstrom HR; Griffith MP; Rangachar Srinivasa V; Wallace NR; Li A; Cooper VS; Shields RK; Van Tyne D Cells; 2024 Feb; 13(5):. PubMed ID: 38474392 [No Abstract] [Full Text] [Related]
17. Phage Milagro: a platform for engineering a broad host range virulent phage for Yao G; Le T; Korn AM; Peterson HN; Liu M; Gonzalez CF; Gill JJ J Virol; 2023 Nov; 97(11):e0085023. PubMed ID: 37943040 [No Abstract] [Full Text] [Related]